Management of pancreatic masses

Daniel Wolfson, Jamie S. Barkin, Suresh T. Chari, Jonathan E. Clain, Richard H. Bell, Nicholas Alexakis, John P. Neoptolemos

Research output: Contribution to journalReview article

35 Scopus citations

Abstract

Dr. William M Steinberg: The 2 sides have been presented. We have read and relearned the differential diagnosis of pancreatic masses. Non-neoplastic masses caused by CP or AIP and certain neoplastic processes such as lymphoma do not require resection. However, percutaneous or EUS-guided biopsy is not perfectly sensitive and cannot always make the diagnosis. Would a negative biopsy prevent the need for surgery, which may not only be curative but palliative? Furthermore, biopsy carries a small but definite risk, which may retard or occasionally complicate subsequent surgery. The reader must make his or her own decision based on the accumulated wisdom presented and discussed in this Controversies section.

Original languageEnglish (US)
Pages (from-to)203-217
Number of pages15
JournalPancreas
Volume31
Issue number3
DOIs
StatePublished - Oct 1 2005

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Fingerprint Dive into the research topics of 'Management of pancreatic masses'. Together they form a unique fingerprint.

  • Cite this

    Wolfson, D., Barkin, J. S., Chari, S. T., Clain, J. E., Bell, R. H., Alexakis, N., & Neoptolemos, J. P. (2005). Management of pancreatic masses. Pancreas, 31(3), 203-217. https://doi.org/10.1097/01.mpa.0000180613.07948.ca